Daniel Skovronsky

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: Myriad Genetics Inc., 3 years.

3 years · Since 2023
Illumina Inc. Director
4 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 2, 2026 Eli Lilly and Company Gift −119 — —
Jun 16, 2026 Illumina Inc. Grant or award +1,674 $164.28 $275,005
Jun 4, 2026 Myriad Genetics Inc. Grant or award +59,701 — —
Feb 9, 2026 Eli Lilly and Company Grant or award +15,548 $1,044.67 $16,242,383
Feb 1, 2026 Eli Lilly and Company Option exercise +12,684 — —
Feb 1, 2026 Eli Lilly and Company Shares withheld for tax −5,641 $1,037.15 $5,850,822
Nov 10, 2025 Eli Lilly and Company Gift −179 — —
Aug 12, 2025 Eli Lilly and Company Open-market purchase +1,000 $634.41 $634,410
Jun 5, 2025 Myriad Genetics Inc. Grant or award +49,796 — —
Feb 10, 2025 Eli Lilly and Company Open-market sale −3,950 $862.69 $3,407,626
Feb 10, 2025 Eli Lilly and Company Open-market sale −340 $863.97 $293,750
Feb 10, 2025 Eli Lilly and Company Open-market sale −710 $865.76 $614,690
Feb 10, 2025 Eli Lilly and Company Grant or award +18,772 $868.88 $16,310,398
Feb 1, 2025 Eli Lilly and Company Option exercise +8,989 — —
Feb 1, 2025 Eli Lilly and Company Shares withheld for tax −4,004 $811.08 $3,247,272

Questions about Daniel Skovronsky

What boards is Daniel Skovronsky on?

Daniel Skovronsky sits on the boards of Illumina Inc. and Myriad Genetics Inc.

How long has Daniel Skovronsky served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.